Business Context and Reporting Period
Company: John Wiley & Sons, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Third quarter and nine months ended January 31, 2005.
Business Overview: A global publisher of print and electronic products, including professional/consumer books, scientific/technical/medical (STM) journals, and educational materials. Operations are segmented into U.S. Professional/Trade, U.S. STM, U.S. Higher Education, Europe, and Asia/Australia/Canada.
Key Financial Metrics
| Metric (in thousands) | 3 Months Ended Jan 31, 2005 | 9 Months Ended Jan 31, 2005 |
|---|---|---|
| Revenue | $258,428 | $732,417 |
| Net Income | $32,791 | $79,134 |
| Diluted EPS | $0.53 | $1.27 |
| Operating Income | $50,425 | $121,326 |
| Cash from Operations (9mo) | $188,835 | |
| Cash and Equivalents (Jan 31, 2005) | $139,841 | |
| Long-Term Debt | $200,000 | |
| Gross Margin (3mo) | 66.8% |
Material Changes vs. Prior Period
- Revenue Growth: Q3 revenue increased 7% ($258.4M vs. $242.4M) and 9-month revenue increased 6% ($732.4M vs. $690.9M). Growth was driven by international operations and U.S. Professional/Trade (P/T) segments.
- Earnings: Diluted EPS rose to $0.53 from $0.50 in the prior year Q3. Excluding a $3.0M one-time tax benefit in the prior year, adjusted EPS increased 18%.
- Segment Performance:
- Professional/Trade: U.S. revenue up 9%; direct contribution to profit up 32% due to lower inventory provisions and strong "For Dummies" sales.
- STM: Global revenue up 8%; U.S. revenue up 2%. Margins compressed slightly due to investments in new society journals and Wiley InterScience.
- Higher Education: U.S. revenue down 3% due to price resistance and softness in engineering/computer science. Direct contribution to profit decreased $2.6M.
- Europe: Revenue up 13% (7% excluding currency), driven by journal and book sales.
- Acquisitions: Acquired the Journal of Microscopy and Analysis ($5.4M) and the Macmillan Nature Publishing Group reference portfolio ($4.5M) during the period.
Outlook, Risks, and Management Commentary
- Capital Allocation: The company continues its stock repurchase program. In Q3, it purchased 444,300 shares; in the nine months, 1.4 million shares. A subsequent event noted the repurchase of 1 million shares from the Bass group for $32.5M on Feb 4, 2005. Dividends were increased to $0.075 per share.
- Tax Legislation: The American Jobs Creation Act of 2004 is expected to favorably impact the effective tax rate. The company is evaluating the repatriation of foreign earnings, with a potential range of $0 to $125 million.
- Accounting Changes: The company will adopt SFAS 123(R) regarding share-based payments in the second quarter of fiscal 2006, which will require expensing stock options.
- Risks:
- Market Risk: Exposure to interest rates (variable rate debt) and foreign exchange fluctuations.
- Credit Risk: Concentration in book wholesalers/retailers (top 10 customers ~25% of revenue) and reliance on subscription agents for journal revenue (~22% of revenue).
- Regulatory: NIH public access policy for journal articles; potential impact on subscription models.
Investor Verification Checklist
- Higher Education Trends: Verify the sustainability of the decline in U.S. Higher Education revenue and margins amidst student price resistance.
- STM Margin Pressure: Assess the long-term impact of investments in new society journals and digital platforms (Wiley InterScience) on STM profitability.
- Tax Rate Normalization: Confirm the actual impact of the American Jobs Creation Act on the effective tax rate in future quarters.
- Stock Repurchase Impact: Monitor the remaining authorization (2.6 million shares) and the effect of the recent $32.5M Bass group transaction on liquidity.
- Foreign Currency Sensitivity: Review the magnitude of currency fluctuations on reported growth, as organic growth rates are lower than reported rates in international segments.